Vigil Neuroscience Inc (NASDAQ:VIGL)’s traded shares stood at 27.75 million during the latest session, with the company’s beta value hitting 1.92. At the last check today, the stock’s price was $7.95, to imply an increase of 244.16% or $5.64 in intraday trading. The VIGL share’s 52-week high remains $6.06, putting it 23.77% up since that peak but still an impressive 83.52% since price per share fell to its 52-week low of $1.31.
Analysts have given a consensus recommendation of Buy for Vigil Neuroscience Inc (VIGL), translating to a mean rating of 2.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give VIGL a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.47.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
After registering a 244.16% upside in the latest session, Vigil Neuroscience Inc (VIGL) has traded red over the past five days. The 5-day price performance for the stock is 242.67%, and 339.23% over 30 days. With these gigs, the year-to-date price performance is 367.65%.
The extremes give us $11 and $11 for target low and target high price respectively. As such, VIGL has been trading -38.36% off suggested target high and -38.36% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -19.68% for the past 5-year period. While 2025 is set for a 11.66% return in earnings, projections for the next 5 years are at 9.27% annually.
VIGL Dividends
Vigil Neuroscience Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is NORTHPOND VENTURES, LLC with 4.21 million shares, or about 10.5722% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $16.86 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and abrdn Life Sciences Investors as the top two Mutual Funds with the largest holdings of the Vigil Neuroscience Inc (VIGL) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 710.14 shares. This is just over 1.52% of the total shares, with a market valuation of $5.62 million. Data from the same date shows that the other fund manager holds a little less at 528.47, or 1.13% of the shares, all valued at about 4.19 million.
